Anderman Todd
SEC CIK 2039533 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| OCUL | OCULAR THERAPEUTIX, INC | CLO | 152.5K | — | $137.4K | 3 | 2024-10-07 | 2026-01-02 |
Most active insiders at OCUL, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Dugel Pravin | See Remarks, Dir | — | $1.94M |
| 2 | LINDSTROM RICHARD L MD | Dir | $461.4K | — |
| 3 | Saroj Namrata | Chief Business Off | — | $277.8K |
| 4 | Heier Jeffrey S. | CSO | — | $243.3K |
| 5 | Kaiser Peter | Chief Development Off | — | $222.9K |
| 6 | Waheed Nadia | Chief Medical Off | — | $220.9K |
| 7 | Notman Donald | See Remarks | — | $216.1K |
| 8 | Nayak Sanjay | Chief Strategy Off | — | $166.4K |
| 9 | Anderman Todd | CLO | — | $137.4K |
| 10 | Robinson David Wayne | Gbl CCO | — | — |
Transactions 3
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-01-06 | 2026-01-02 | OCUL | OCULAR THERAPEUTIX, INC | Anderman Todd | CLO | A - Grant | $0.00 | +64.9K | 152.5K | +74% | $0 |
| 2025-10-10 | 2025-10-08 | OCUL | OCULAR THERAPEUTIX, INC | Anderman Todd | CLO | S - Sale | $12.34 | -11.1K | 87.6K | -11% | -$137.4K | |
| D | 2024-10-09 | 2024-10-07 | OCUL | OCULAR THERAPEUTIX, INC | Anderman Todd | CLO | A - Grant | $0.00 | +98.7K | 98.7K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations